Alcudacigib (TFA)
Alcudacigib (Compound 9) TFA is an inhibitor of DGKζ. Alcudacigib TFA can be used for research in cancer related to immunocyte activation or cancer resistant to anti-PD-1 antibody/anti-PD-L1 antibody[1].
Product Specifications
Product Name Alternative
DGKζ-IN-1 (TFA)
UNSPSC
12352005
Target
DGK
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer
Purity
99.72
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
FC(F)(C1=C(N2C[C@@H](CCC2)CN)C(NC(C3=CSC(C4=CN=NC=C4)=N3)=O)=CC=C1OC5=CC=CC=C5)F.OC(C(F)(F)F)=O
Molecular Formula
C29H26F6N6O4S
Molecular Weight
668.61
References & Citations
[1]Watanabe H, et al. Preparation of pyridazinyl-thiazolecarboxamide compound as DGKζ inhibitor. World Intellectual Property Organization, WO2021132422 A1. 2021-07-01.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K6751905 3x 1.0 µg
Dlk2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)
Sign In for Pricing
View Details